COMMUNIQUÉS West-GlobeNewswire

Grace Therapeutics to Participate in the 2025 BIO International Conference
13/06/2025
PRINCETON, N.J., June 13, 2025 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable [...]
Processa Pharmaceuticals to Engage Potential Partners and Investors at BIO International Convention 2025
13/06/2025
HANOVER, Md., June 13, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) , a clinical-stage pharmaceutical company developing Next Generation Cancer (NGC) therapies, today announced that members of [...]
Indaptus Therapeutics, Inc. Announces Sale of $2.3 Million in Private Placement of Convertible Notes and Warrants
13/06/2025
NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus”), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today [...]
BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease
13/06/2025
– The International Society for Stem Cell Research (“ISSCR”) 2025 Annual Meeting is the world’s foremost gathering of stem cell and regenerative medicine leaders – – Updated data presented at ISSCR 2025 demonstrates [...]
Sensei Biotherapeutics Announces 1-for-20 Reverse Stock Split
13/06/2025
BOSTON, June 13, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients [...]
Altimmune Announces Multiple Presentations at Upcoming American Diabetes Association’s Scientific Sessions
13/06/2025
GAITHERSBURG, Md., June 13, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, [...]
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
13/06/2025
LONDON, June 13, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced that its Chairman of the Board, [...]
Arvinas Presents Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at the European Hematology Association 2025 Congress
13/06/2025
– ARV-393 demonstrated significant single-agent activity in models of nodal T-follicular helper cell lymphoma, angioimmunoblastic-type (also known as AITL) and transformed follicular lymphoma – – In combination with [...]
Fractyl Health to Present New Preclinical Data from its Rejuva® Smart GLP-1™ Pancreatic Gene Therapy Platform at the American Diabetes Association's 85th Scientific Sessions
13/06/2025
BURLINGTON, Mass., June 13, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company), a metabolic therapeutics company focused on pattern-breaking approaches to treat the root causes of obesity and [...]
Tonix Pharmaceuticals Announces Appointment of Commercial Industry Veteran, James “Jim” Hunter, to Board of Directors
13/06/2025
Mr. Hunter brings more than 40 years of experience building and leading commercial organizations in the biopharmaceutical industry, including leadership roles at Validus Pharmaceuticals, Relialab and Novartis Led launch [...]
ORLADEYO® (berotralstat) Approved in Colombia
13/06/2025
RESEARCH TRIANGLE PARK, N.C., June 13, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the National Institute of Drug and Food Surveillance (INVIMA) in Colombia has granted [...]
Biomea Fusion Presents Updated Preliminary Clinical Data for Covalent FLT3 Inhibitor BMF-500 in Relapsed or Refractory Acute Leukemia at EHA 2025
13/06/2025
New clinical results show sustained CRi, deep bone marrow responses, and encouraging survival in FLT3-mutant AML patients, including those previously treated with gilteritinib REDWOOD CITY, Calif., June 13, 2025 (GLOBE [...]
RetinalGenix Technologies Welcomes Dr. Taimour Langaee as Advisor for DNA GPS Pharmacogenetics Initiatives
13/06/2025
Appointment Underscores RetinalGenix’s Commitment to Integrating the Latest Advances in Genomics and Personalized Medicine into its Product Pipeline APOLLO BEACH, Fla., June 13, 2025 (GLOBE NEWSWIRE) -- RetinalGenix [...]
ITM to Provide COMPETE Trial Insights at SNMMI 2025 Annual Meeting in Oral Presentation and Satellite Symposium
13/06/2025
Garching / Munich, Germany, June 13, 2025 – ITM Isotope Technologies Munich SE (ITM) , a leading radiopharmaceutical biotech company, today announced that it will provide further analysis from its recently completed [...]
Dogecoin Cash, Inc. Acquires 420 Million DOG Tokens and AltcoinMarketCap.com Domain
13/06/2025
Strategic Digital Asset Expansion Adds to Company’s Ecosystem Holdings Mesquite,NV, June 13, 2025 (GLOBE NEWSWIRE) -- Dogecoin Cash, Inc. (OTCQB: DOGP), a Nevada-based public company focused on technology and digital [...]
Plant Advanced TEchnologies ($ALPAT) : Modalités de mise à disposition du Rapport Annuel Financier 2024
13/06/2025
Vandœuvre-lès-Nancy, le 13 juin 2025 - 08 : 00 (CET) Communiqué de presse Pour diffusion immédiate Mise à disposition du Rapport Financier Annuel 2024 Plant Advanced Technologies PAT ( Euronext Growth™- Paris - [...]
Avextra Cannabis extract can potentially reduce symptom burden for late palliative patients
13/06/2025
New Study Demonstrates Significant Symptom Relief for Late-Stage Palliative Patients Treated with Cannabis-based Medicines Bensheim, Germany – 13th June 2025 – According to the World Health Organization, an estimated 56 [...]
Invitation to attend the extraordinary shareholders’ meeting of the Company to be held on July 2, 2025
13/06/2025
REGULATED INFORMATION June 13, 2025, 7:00am CET / 1:00am ET NYXOAH SA (Euronext Brussels/Nasdaq: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium (hereinafter the “ Company ”) Invitation to attend the [...]
Invitation à assister à l'assemblée générale extraordinaire des actionnaires de la Société qui se tiendra le 2 juillet 2025
13/06/2025
INFORMATIONS RÉGLEMENTÉES le 13 juin 2025, 7:00h CET / 1:00h ET NYXOAH SA (Euronext Brussels/Nasdaq: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgique (ci-après la « Société ») Invitation à assister à l' [...]

Pages